Biphasic anaphylaxis - Symptoms, Causes, Treatment & Prevention

```html

Overview

Biphasic anaphylaxis is a two‑stage severe allergic reaction in which the initial symptoms improve or resolve, only to recur 1–72 hours later without further exposure to the trigger. The second “phase” can be as intense as the first, and it may occur even after appropriate emergency treatment.

• Who it affects: It can occur in anyone with a prior anaphylactic reaction—children, adolescents, adults, and older adults. Certain groups—such as people with asthma, a history of severe anaphylaxis, or multiple drug allergies—are more likely to experience a biphasic pattern.
• Prevalence: Reports vary, but epidemiologic studies suggest that 1–20 % of anaphylaxis cases are biphasic.<sup>1,2</sup> In large emergency‑department series, roughly 5‑10 % of patients develop a second phase.

Understanding biphasic anaphylaxis is essential because the delayed recurrence can be mistaken for recovery, leading to premature discharge from the emergency department (ED) and increased risk of life‑threatening complications.

Symptoms

The symptom profile mirrors that of a typical anaphylactic reaction, but it can appear in two separate waves. Below is a complete list, grouped by organ system, with brief descriptions.

Skin and Mucosal Tissue

• Urticaria (hives): Raised, itchy, red or skin‑colored welts that may change shape rapidly.
• Angio‑edema: Swelling of deeper layers, often of the lips, eyelids, tongue, or face.
• Flushing: Warm, reddish discoloration of the skin.
• Pruritus: Generalized itching, sometimes preceding hives.

Respiratory Tract

• Dyspnea (shortness of breath): May feel like “tightness” in the chest.
• Wheezing / Stridor: High‑pitched noises on breathing, indicating airway narrowing.
• Throat tightness or “globus” sensation: Feeling of a lump in the throat.
• Cough or hoarseness: Result of laryngeal edema.
• Bronchospasm: Constriction of the airways, especially in asthmatic patients.

Cardiovascular System

• Hypotension: Systolic blood pressure < 90 mmHg or a drop >30 % from baseline.
• Syncope or dizziness: Due to reduced cerebral perfusion.
• Tachycardia: Compensatory fast heart rate.
• Arrhythmias: Rare but possible, especially with medications that prolong QT.

Gastrointestinal Tract

• Nausea / Vomiting
• Abdominal pain
• Diarrhea

Neurologic

• Headache
• Confusion or altered mental status (especially with severe hypotension).

Other

• Metallic taste in the mouth.
• Generalized weakness and sense of impending doom.

In biphasic anaphylaxis, any of the above may appear during the second phase, often after a period of apparent stability lasting from minutes to several hours.

Causes and Risk Factors

Biphasic anaphylaxis is not a separate disease; it is a pattern of reaction to the same triggers that cause classic anaphylaxis.

Common Triggers

• Foods: Peanuts, tree nuts, shellfish, fish, milk, egg, sesame.
• Medications: Antibiotics (especially β‑lactams), non‑steroidal anti‑inflammatory drugs (NSAIDs), radiocontrast agents, neuromuscular blocking agents.
• Insect stings: Bees, wasps, fire ants.
• Latex and other occupational allergens.

Risk Factors for a Biphasic Pattern

• Severe initial reaction: Hypotension, respiratory compromise, or need for multiple epinephrine doses.<sup>3</sup>
• Delayed or insufficient epinephrine administration: Early, adequate dosing reduces biphasic risk.
• Presence of asthma or chronic lung disease: Airway hyper‑reactivity predisposes to prolonged inflammation.
• Older age (≥ 65 years): Slower metabolism of mediators.
• Concurrent use of β‑blockers or ACE inhibitors: May blunt response to epinephrine.
• Elevated serum tryptase or baseline mastocytosis: Indicates higher mast‑cell burden.

Diagnosis

Because biphasic anaphylaxis is defined by its temporal pattern, diagnosis is primarily clinical.

Initial Assessment

1. History: Identify exposure to a known allergen, timing of symptom onset, and any prior anaphylaxis.
2. Physical Examination: Look for skin changes, airway compromise, cardiovascular instability, and GI symptoms.
3. Vital Signs: Blood pressure, heart rate, respiratory rate, oxygen saturation.

Laboratory Tests (Adjunctive)

• Serum tryptase: Peaks 1–2 h after symptom onset; a level >1.2 × baseline supports mast‑cell activation. A second sample 24 h later can help confirm biphasic response if the first was normal.
• Complete blood count (CBC): May show eosinophilia in chronic allergic states.
• Basic metabolic panel: Evaluates renal function, electrolytes, and glucose, especially if steroids are used.

Imaging (Only if Indicated)

• Chest X‑ray if respiratory distress is severe or to rule out other causes of dyspnea.
• CT angiography if suspicion for pulmonary embolism exists (rare in anaphylaxis).

Diagnostic Criteria for Biphasic Anaphylaxis

According to the World Allergy Organization, a biphasic reaction is present when:

• Allergic symptoms recur ≥ 1 hour after complete resolution of the first phase, without re‑exposure to the trigger.
• The second phase manifests with any of the organ‑system symptoms listed above and may require additional treatment.

Treatment Options

Management follows the same algorithm as classic anaphylaxis, with special attention to observation time and readiness for a second wave.

Emergency Medications

1. Epinephrine (adrenaline): First‑line. Intramuscular (IM) injection into the mid‑outer thigh (0.3 mg of 1 mg/mL for adults; 0.01 mg/kg for children, max 0.3 mg) as soon as anaphylaxis is recognized. Repeat every 5‑15 minutes if symptoms persist.
2. Antihistamines:
   • H1‑blockers (e.g., diphenhydramine 25‑50 mg IM/IV).
   • Optional H2‑blocker (e.g., ranitidine 50 mg IV) for additive effect on cutaneous symptoms.
3. Corticosteroids: Not life‑saving acutely, but may reduce late-phase inflammation. Common choices: methylprednisolone 125 mg IV or prednisone 1 mg/kg PO.
4. Bronchodilators: Albuterol nebulization for bronchospasm or wheeze.
5. Airway management: Supplemental oxygen, nebulized epinephrine, or endotracheal intubation if airway obstruction is imminent.

Observation and Monitoring

• Standard recommendation: minimum 4‑6 hours of observation after symptom resolution; however, many experts suggest 12‑24 hours for high‑risk patients (severe first phase, asthma, need for multiple epinephrine doses).<sup>4</sup>
• Continuous pulse oximetry, serial blood pressure checks, and repeat physical exams every 30‑60 minutes.

Disposition

• Discharge: Only after stable vitals, resolution of symptoms, and an observation period that meets risk‑based guidelines.
• Admission: Consider for patients with:
  • Persistent hypotension or respiratory distress.
  • History of biphasic reactions.
  • Comorbidities (e.g., severe asthma, cardiac disease).

Long‑Term Management

• Epinephrine auto‑injector prescription: One for every at‑risk individual, plus a spare. Train patients and caregivers on proper use.
• Allergy referral: Skin prick or specific IgE testing to identify trigger and guide avoidance strategies.
• Education: Written anaphylaxis action plan, medical alert bracelet, and emergency contact list.

Living with Biphasic Anaphylaxis

Beyond the acute episode, individuals must adopt strategies that reduce anxiety, improve safety, and ensure rapid response if a second phase occurs.

Daily Management Tips

• Carry two epinephrine auto‑injectors: One in a readily accessible place (e.g., purse), another in a backup location (e.g., car).
• Review your action plan weekly: Keep it updated after any new allergy testing or medication changes.
• Maintain a symptom diary: Note exposures, timing, and response to treatment; this aids clinicians in identifying patterns.
• Educate close contacts: Family, friends, coworkers, and school staff should know how to recognize anaphylaxis and where the injectors are stored.
• Medical alert identification: Wear a bracelet or necklace that lists “Biphasic Anaphylaxis – Carry Epinephrine.”
• Manage comorbid asthma: Daily inhaled corticosteroids and rescue inhalers reduce airway hyper‑reactivity.
• Medication review: Discuss all prescriptions and over‑the‑counter drugs with your doctor to avoid hidden allergens (e.g., latex in vial stoppers).

Psychological Considerations

Fear of recurrence can lead to anxiety or avoidance of social activities. Cognitive‑behavioral therapy, support groups, and counseling are effective tools. Resources such as the Food Allergy Research & Education (FARE) community can provide peer support.

Prevention

Prevention focuses on avoiding known triggers and preparing for accidental exposures.

Trigger Avoidance

1. Read labels: Look for the “contains” and “may contain” statements on packaged foods.
2. Ask about ingredients: When dining out, communicate your allergy clearly to staff and request a written ingredient list.
3. Medication safety: Verify inactive ingredients; request allergy‑free formulations when possible.
4. Insect protection: Wear long sleeves, use insect repellent, and keep emergency epinephrine on hand during outdoor activities.

Vaccination and Immunotherapy

• For select food allergies, oral immunotherapy (OIT) can increase tolerance, but it must be done under specialist supervision because it may provoke biphasic reactions.
• Allergy desensitization via subcutaneous immunotherapy (SCIT) is effective for insect‑venom allergy and can reduce the risk of severe reactions.

Preparedness Measures

• Keep epinephrine in a temperature‑controlled environment (15‑30 °C) and replace after the expiration date.
• Enroll in an anaphylaxis training course offered by local hospitals, allergy societies, or the American Academy of Allergy, Asthma & Immunology (AAAAI).
• Update your emergency plan after any new reaction or change in health status.

Complications

When not promptly recognized or inadequately treated, biphasic anaphylaxis can lead to serious outcomes, some of which are more likely during the second phase.

• Airway obstruction: Laryngeal edema may be more pronounced after the initial edema subsides, making intubation more difficult.
• Cardiovascular collapse: A delayed hypotensive episode can occur when circulating mediators rebound.
• Acute renal injury: Resulting from hypotension and mast‑cell mediator–induced vasoconstriction.
• Neurologic sequelae: Prolonged hypoxia can lead to seizures or permanent cognitive deficits.
• Psychological impact: Recurrent episodes can cause post‑traumatic stress disorder (PTSD) or severe health anxiety.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Anaphylaxis: Symptoms, causes, and treatment. 2023.
2. Simons FER. Anaphylaxis: Past, present, and future. J Allergy Clin Immunol. 2019;143(2):381‑387.
3. Brown SG, et al. Risk factors for biphasic anaphylaxis: A systematic review. Ann Allergy Asthma Immunol. 2021;126(3):272‑279.
4. World Allergy Organization (WAO) Guidelines for Anaphylaxis, 2022. worldallergy.org

```